logo
NasdaqGM:RANI logo

Rani Therapeutics Holdings Community

NasdaqGM:RANI Community
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 7 Fair Values set on narratives written by author
Create a narrative

Community Investing Ideas

RANI logo
Rani Therapeutics Holdings
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts

RT-114 And Pill Technology Will Transform Obesity Treatments

Key Takeaways RaniPill technology and RT-114 partnership position Rani Therapeutics to capture significant market share and boost future revenue. Extensive patent portfolio and cost containment measures enhance protection, licensing opportunities, and improve net margins.
View narrative
US$9.50
FV
88.6% undervalued intrinsic discount
129.84%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
6users have followed this narrative
2 days ago author updated this narrative